Transfer of IFNγR-deficient OTI overall enhanced mouse survival (Fig. 8a), slowed tumor growth (Fig. 8b) and decreased tumor weight (Fig. 8c), demonstrating that IFNγR ablation in adoptively transferred T cells improved tumor control. Here, IFNGR1 is linked to neoplasm.